FDA Approves Implant for Bladder Control

FDA Approves Implant for Bladder Control

Overactive bladder (OAB) syndrome affects more than 37 million people in the U.S. to some degree. Some estimate the cost to the country’s healthcare system in the range of $60 billion every year. StimGuard is a company that has developed a novel treatment for...